RT Journal Article
SR Electronic
T1 Assessment of N95 respirator decontamination and re-use for SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.11.20062018
DO 10.1101/2020.04.11.20062018
A1 Robert J. Fischer
A1 Dylan H. Morris
A1 Neeltje van Doremalen
A1 Shanda Sarchette
A1 M. Jeremiah Matson
A1 Trenton Bushmaker
A1 Claude Kwe Yinda
A1 Stephanie N. Seifert
A1 Amandine Gamble
A1 Brandi N. Williamson
A1 Seth D. Judson
A1 Emmie de Wit
A1 James O. Lloyd-Smith
A1 Vincent J. Munster
YR 2020
UL http://medrxiv.org/content/early/2020/04/24/2020.04.11.20062018.abstract
AB The unprecedented pandemic of SARS-CoV-2 has created worldwide shortages of personal protective equipment, in particular respiratory protection such as N95 respirators. SARS-CoV-2 transmission is frequently occurring in hospital settings, with numerous reported cases of nosocomial transmission highlighting the vulnerability of healthcare workers. In general, N95 respirators are designed for single use prior to disposal. Here, we have analyzed four readily available and often used decontamination methods: UV, 70% ethanol, 70C heat and vaporized hydrogen peroxide for inactivation of SARS-CoV-2 on N95 respirators. Equally important we assessed the function of the N95 respirators after multiple wear and decontamination sessions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). JOL-S and AG were supported by the Defense Advanced Research Projects Agency DARPA PREEMPT # D18AC00031 and the UCLA AIDS Institute and Charity Treks, and JOL-S was supported by the U.S. National Science Foundation (DEB-1557022), the Strategic Environmental Research and Development Program (SERDP, RC-2635) of the U.S. Department of Defense. no payment was received from third parties.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data to reproduce the Bayesian estimation results and produce corresponding figures are archived online at OSF: and available on Github: